Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins (Q43760062)

26 November 2017

Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins (English)

1 reference

26 November 2017

0 references

9

1 reference

26 November 2017

Degraeve F

1

1 reference

26 November 2017

Bolla M

2

1 reference

26 November 2017

Blaie S

3

1 reference

26 November 2017

Créminon C

4

1 reference

26 November 2017

Quéré I

5

1 reference

26 November 2017

Boquet P

6

1 reference

26 November 2017

Lévy-Toledano S

7

1 reference

26 November 2017

Bertoglio J

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

8 October 2001

1 reference

Journal of Biological Chemistry

26 November 2017

1 reference

26 November 2017

276

1 reference

26 November 2017

46849-46855

1 reference

26 November 2017

50

1 reference

Regulation of the mevalonate pathway

26 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Lipid modifications of G proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Protein prenyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Prostaglandin and thromboxane biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Resistance to ciprofloxacin appearing during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Rho GTPases and their effector proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Glucosylation of Rho proteins by Clostridium difficile toxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the Rho GTPase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Effects of a competitive inhibitor (mevinolin) of 3-hydroxy-3-methylglutaryl coenzyme A reductase on human and bovine endothelial cells, fibroblasts and smooth muscle cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Human cyclooxygenase-2 cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Interleukin-1 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Neuroprotective properties of statins in cerebral ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Direct vascular effects of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M104197200

21 January 2018

Identifiers

DOI

10.1074/JBC.M104197200

1 reference

26 November 2017

1 reference